Circ_0058063 regulates cell vitality and proliferation in oesophageal squamous-cell carcinomas.
ATIC
THBS1
apoptosis
invasion
miR-4319
proliferation
Journal
Journal of biochemical and molecular toxicology
ISSN: 1099-0461
Titre abrégé: J Biochem Mol Toxicol
Pays: United States
ID NLM: 9717231
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
03
07
2023
received:
31
07
2022
accepted:
08
07
2023
medline:
10
11
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
Oesophageal squamous-cell carcinoma (ESCC) is a malignant tumor of the digestive system with a poor prognosis. Recent studies have shown the promoting effect of hsa_circ_0058063 (circ_0058063) on ESCC, but the potential regulatory mechanisms of circ_0058063 in ESCC remain largely unclear. The levels of circ_0058063, microRNA-4319 (miR-4319) and mRNA of thrombospondin-1 (THBS1) were indicated by quantitative real-time polymerase chain reaction in ESCC tissues and cells. Meanwhile, the level of THBS1 was quantified by western blot analysis. In addition, the cell functions were examined by CCK8 assay, Edu assay, flow cytometry assay and transwell assay. Furthermore, the interplay between miR-4319 and circ_0058063 or THBS1 was detected by dual-luciferase reporter assay. Finally, an in vivo experiment was implemented to confirm the effect of circ_0058063. The level of circ_0058063 and THBS1 were increased, and the miR-4319 level was decreased in ESCC tissues in contrast to that in normal tissues and cells. For functional analysis, circ_0058063 deficiency inhibited cell vitality, cell proliferation, migration and invasion in ESCC cells, whereas promoted cell apoptosis. Moreover, miR-4319 was confirmed to repress the progression of ESCC cells by suppressing THBS1. In mechanism, circ_0058063 acted as a miR-4319 sponge to regulate the level of THBS1. Besides, circ_0058063 knockdown also attenuated tumour growth in vivo. Circ_0058063 facilitates the development of ESCC through increasing THBS1 expression by regulating miR-4319, which also offered an underlying targeted therapy for ESCC treatment.
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e23470Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
A. Pennathur, M. K. Gibson, B. A. Jobe, J. D. Luketich, Lancet 2013, 381(9864), 400.
F. Kamangar, G. M. Dores, W. F. Anderson, J. Clin. Oncol. 2006, 24(14), 2137.
P. C. Enzinger, R. J. Mayer, N. Engl. J. Med. 2003, 349(23), 2241.
S. He, J. Xu, X. Liu, Y. Zhen, Acta Pharm. Sin. B 2021, 11(11), 3379.
J. K. Waters, S. I. Reznik, Curr. Oncol. Rep. 2022, 24(3), 375.
V. Ambros, Nature 2004, 431(7006), 350.
R. Garzon, G. Marcucci, C. M. Croce, Nat. Rev. Drug Discovery 2010, 9(10), 775.
J. Greene, A. M. Baird, L. Brady, M. Lim, S. G. Gray, R. McDermott, S. P. Finn, Front. Mol. Biosci. 2017, 4, 38.
J. Q. Sheng, L. Liu, M. R. Wang, P. Y. Li, Am. J. Cancer Res. 2018, 8(7), 1142.
R. Peng, J. Cao, B. B. Su, X. Bai, X. Jin, A. Wang, Q. Wang, R. Liu, G. Jiang, S. Jin, C. Zhang, D. Bai, Cancer Lett. 2022, 543, 215778.
Z. Xu, S. Chen, R. Liu, H. Chen, B. Xu, W. Xu, M. Chen, Mol. Cancer 2022, 21(1), 146.
P. Wu, J. Qin, L. Liu, W. Tan, L. Lei, J. Zhu, Aging 2022, 14, 5406.
Q. He, L. Huang, D. Yan, J. Bi, M. Yang, J. Huang, T. Lin, Aging 2019, 11(23), 11314.
J. Liu, N. Xue, Y. Guo, K. Niu, L. Gao, S. Zhang, H. Gu, X. Wang, D. Zhao, R. Fan, Aging 2019, 11(24), 12412.
X. Hu, D. Wu, X. He, H. Zhao, Z. He, J. Lin, K. Wang, W. Wang, Z. Pan, H. Lin, M. Wang, Mol. Cancer 2019, 18(1), 160.
Z. Pan, J. Lin, D. Wu, X. He, W. Wang, X. Hu, L. Zhang, M. Wang, Aging 2019, 11(24), 11937.
Y. Zheng, Y. Chen, H. Jiang, H. Zhang, H. Wang, J. Xu, Z. Yu, J. Thorac. Dis. 2020, 12(3), 925.
B. Zhang, W. Chu, Z. Li, Y. Zhang, Q. Zhen, B. Lv, J. Liu, C. Lu, X. Zhao, Biochem. Genet. 2022, 60(5), 1585.
B. He, Z. Zhao, Q. Cai, Y. Zhang, P. Zhang, S. Shi, H. Xie, X. Peng, W. Yin, Y. Tao, X. Wang, Int. J. Biol. Sci. 2020, 16(14), 2628.
R. Rupaimoole, F. J. Slack, Nat. Rev. Drug Discovery 2017, 16(3), 203.
L. Huang, Y. Zhang, Z. Li, X. Zhao, Z. Xi, H. Chen, H. Shi, T. Xin, R. Shen, T. Wang, United European Gastroenterol. J. 2019, 7(4), 517.
X. Hu, M. Wang, L. Cao, L. Cong, Y. Gao, J. Lu, J. Feng, B. Shen, D. Liu, Curr. Mol. Pharmacol.2020, 13(2), 144.
S. Bian, J. Cell. Biochem. 2020, 121(1), 174.
Y. Lu, J. Yu, Z. Yang, G. Zhu, P. Gao, H. Wang, S. Chen, J. Zhang, M. Liu, Y. Niu, X. Wei, W. Wang, F. Ye, L. Zhang, Y. Zhao, G. Sun, J. Exp. Clin. Cancer Res. 2018, 37(1), 301.
H. Liu, G. Ren, L. Zhu, X. Liu, X. He, Tumor Biol. 2016, 37(4), 4641.
J. S. Isenberg, D. D. Roberts, Atlas Genet. Cytogenet. Oncol. Haematol. 2020, 24(8), 291.
S. Filleur, O. V. Volpert, A. Degeorges, C. Voland, F. Reiher, P. Clézardin, N. Bouck, F. Cabon, Genes Dev. 2001, 15(11), 1373.
V. Firlej, J. R. R. Mathieu, C. Gilbert, L. Lemonnier, J. Nakhlé, C. Gallou-Kabani, B. Guarmit, A. Morin, N. Prevarskaya, N. B. Delongchamps, F. Cabon, Cancer Res. 2011, 71(24), 7649.
J. Lawler, J. Cell. Mol. Med. 2002, 6(1), 1.
Y. Ma, B. Qu, X. Xia, L. Yang, Y. Kuang, T. Yang, J. Cheng, H. Sun, K. Fan, J. Gu, Cancer Invest. 2015, 33(4), 152.
L. Y. Chen, Z. Zhi, L. Wang, Y. Y. Zhao, M. Deng, Y. H. Liu, Y. Qin, M. M. Tian, Y. Liu, T. Shen, L. N. Sun, J. M. Li, J. Pathol. 2019, 248(1), 103.
Y. Wu, Y. Zhang, X. Zheng, F. Dai, Y. Lu, L. Dai, M. Niu, H. Guo, W. Li, X. Xue, Y. Bo, Y. Guo, J. Qin, Y. Qin, H. Liu, Y. Zhang, T. Yang, L. Li, L. Zhang, R. Hou, S. Wen, C. An, H. Li, W. Xu, W. Gao, Mol. Cancer 2020, 19(1), 99.
L. Sebastian, C. Pawlicki, A. Wessel, Kans. Nurse 1988, 63(8), 2.
F. Li, L. Zhang, W. Li, J. Deng, J. Zheng, M. An, J. Lu, Y. Zhou, Oncotarget 2015, 6(8), 6001.
X. Li, L. Ding, G. Gu, C. Zheng, C. Pan, Q. Zheng, T. Xiang, Evid. Based Complementary Altern. Med. 2021, 2021, 4630934.
M. Tang, F. Wang, K. Wang, Y. Jiang, Q. Wang, Anti-cancer drugs 2022, 33(7), 642.
J. Yu, Y. Lou, M. Hou, X. Ma, L. Wang, J. Oral Pathol. Med. 2022, 51(7), 630.
M. Sun, X. Liu, W. Zhao, B. Zhang, P. Deng, BMC Cancer 2022, 22(1), 313.
Y. Shi, N. Fang, Y. Li, Z. Guo, W. Jiang, Y. He, Z. Ma, Y. Chen, Cancer Sci. 2020, 111(8), 2824.
Z. Xu, X. Tie, N. Li, Z. Yi, F. Shen, Y. Zhang, IUBMB Life 2020, 72(3), 426.
J. Chu, Y. Li, X. Fan, J. Ma, J. Li, G. Lu, Y. Zhang, Y. Huang, W. Li, X. Huang, Z. Fu, Y. Yin, H. Yuan, Cell. Physiol. Biochem. 2018, 48(2), 593.
Y. Wang, H. Zhao, W. Zhi, Cancer Biol. Ther. 2020, 21(2), 122.
S. Patwardhan, P. Mahadik, O. Shetty, S. Sen, Biomaterials 2021, 279, 121185.
M. Xiao, J. Zhang, W. Chen, W. Chen, J. Exp. Clin. Cancer Res. 2018, 37(1), 143.
X. Chen, Z. Q. Guo, D. Cao, Y. Chen, J. Chen, Cell Death Dis. 2021, 12(3), 244.
J. Shen, B. Cao, Y. Wang, C. Ma, Z. Zeng, L. Liu, X. Li, D. Tao, J. Gong, D. Xie, J. Exp. Clin. Cancer Res. 2018, 37(1), 175.
F. Bonnet-Magnaval, L. H. Diallo, V. Brunchault, N. Laugero, F. Morfoisse, F. David, E. Roussel, M. Nougue, A. Zamora, E. Marchaud et al, Int. J. Mol. Sci. 2021, 23(1), 215.
Z. Q. Zhou, W. H. Cao, J. J. Xie, J. Lin, Z. Y. Shen, Q. Y. Zhang, J. H. Shen, L. Y. Xu, E. M. Li, BMC Cancer 2009, 9, 291.
H. Pawar, M. K. Kashyap, N. A. Sahasrabuddhe, S. Renuse, H. C. Harsha, P. Kumar, J. Sharma, K. Kandasamy, A. Marimuthu, B. Nair, S. Rajagopalan, J. Maharudraiah, C. S. Premalatha, K. V. Kumar, M. Vijayakumar, R. Chaerkady, T. S. Prasad, R. V. Kumar, R. V. Kumar, A. Pandey, Cancer Biol. Ther. 2011, 12(6), 510.